CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Metabolic Rate Monitoring Of Undifferentiated iPS Cells And Expression Analysis Of Differentiation Markers

  Continuous tracking of glucose and lactate kinetics provides clear quantitative indicators of stem cell pluripotency and early differentiation to optimize culture timing.

• Control pH Adjustment And Reduce Complexity

  Learn how automated, banded pH control uses dose-and-wait logic to limit overshoot, account for mixing and buffer effects, and maintain stable setpoints across changing fill volumes.

• Nucleic Acid-LNP Ultrafiltration And Diafiltration

  Downstream filtration can make or break LNPs at scale. See how membrane format, loading, and shear affect recovery and stability — and how alternative TFF lowers scale‑up risk.

• Can Your Biopharma Team Keep Unplanned Downtime At Bay?

  Learn how teams reduce downtime, strengthen compliance, and respond quickly to equipment issues through proactive maintenance, smart spare parts planning, and digital troubleshooting tools.

• Beyond Protein A: Efficient Purification Strategies For Misbehaving mAbs

  Next-generation antibody formats require more precise purification strategies. Explore how subdomain-specific VHH ligands can address structural heterogeneity, improve purity, and preserve stability.

• Improved T Cell Expansion Using Closed, Automated Stirred-Tank Bioreactors

  A shift from traditional rocking motion systems to stirred-tank bioreactors can enhance T cell expansion, offering greater scalability and more intimate process control.

• A Risk-Based Approach To Plasmid DNA And mRNA Process Development

  Balancing robust analytics and clinical readiness is key for early-phase pDNA and mRNA therapeutics amid structural complexity and regulatory challenges.

• Early Discovery Of Functional Antibody Leads

  Early functional screening accelerates therapeutic antibody discovery, improving hit rates and efficiency through advanced platforms like hybridoma upgrades, single B cell workflows, and tailored phage display strategies.

• A Model To Produce CAR-T, Anywhere

  Standardized point-of-care manufacturing overcomes cell therapy access, cost, and supply challenges, enabling regional centers to efficiently deliver high-quality treatments.

• Maximizing MSC Yield And Quality: A Comparative Media Study

  Maximize mesenchymal stem cell (MSC) expansion with a simplified culture process. New data demonstrates a high-performance, xeno-free media that eliminates the need for coatings or media exchanges.